News
Gain Therapeutics Reports Results From Single Ascending Dose Part Of Phase 1 Clinical Trial Of GT-02287, Novel GCase-Targeting Small Molecule Therapy For GBA1 Parkinson's Disease
24 Apr 24
Biotech, News, General
Oppenheimer Maintains Outperform on Gain Therapeutics, Maintains $9 Price Target
23 Apr 24
News, Price Target, Analyst Ratings
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
2 Apr 24
Long Ideas, News, Penny Stocks, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
Chardan Capital Reiterates Buy on Gain Therapeutics, Maintains $6 Price Target
27 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Gain Therapeutics Q4 EPS $(0.29) Beats $(0.32) Estimate
26 Mar 24
Earnings, News
Gain Therapeutics: Q4 Earnings Insights
26 Mar 24
Earnings
Gain Therapeutics FY23 EPS $(1.71) Vs $(1.48) YoY
26 Mar 24
Earnings, News
Market-Moving News for March 5th
5 Mar 24
Movers, Trading Ideas
EXCLUSIVE: Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson's Disease
5 Mar 24
Biotech, News, Health Care, Top Stories, Market-Moving Exclusives, Exclusives, General
Gain Therapeutics' CEO Matthias Alder Issues Letter To Shareholders
31 Jan 24
News
Press releases
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson's Disease
24 Apr 24
Press Releases
Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
8 Apr 24
News, Management, Press Releases
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer
1 Apr 24
Press Releases
Gain Therapeutics to Present at Public Ventures Discovery Day
15 Mar 24
News, Management, Press Releases
Gain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson's Disease
27 Feb 24
Press Releases
Gain Therapeutics Announces 2024 R&D Update on Parkinson's Disease with KOL & Analyst Insight
14 Feb 24
News, Press Releases